Table 1.
Patient characteristics in genotype guided statin therapy (GGST) and control groups.
| Characteristic | GGST (N = 58) | Control (N = 59) | p* |
|---|---|---|---|
| Age (SD) | 63.6 (9.0) | 63.6 (13.3) | 0.98 |
| Sex, male (%) | 21 (36.2) | 14 (23.7) | 0.16 |
| Race, white (%) | 46 (79.3) | 38 (64.4) | 0.10 |
| BMI (SD) | 30.4 (5.3) | 32.2 (9.7) | 0.22 |
| History of smoking (%) | 11 (19.0) | 16 (27.1) | 0.38 |
| Number of medical comorbidities (SD) | 3.8 (1.6) | 3.6 (1.2) | 0.41 |
| Total cholesterol, mg/dL (SD), N = 98 | 217.3 (57.0) | 198.2 (42.6) | 0.06 |
| HDL-c, mg/dL (SD), N = 98 | 51.0 (12.7) | 49.9 (13.4) | 0.69 |
| LDL-c, mg/dL (SD), N = 99 | 146.4 (51.9) | 122.8 (35.6) | 0.009 |
| NCEP goal at baseline (%), N = 99 | 16 (44.4) | 20 (55.6) | 0.25 |
| Clinic, Pickett Road (%) | 54 (93.1) | 57 (96.6) | 0.44 |
* All statistical tests compared the GGST group to the control group. Two-sided t-test was used for continuous variables and Fisher’s exact test for categorical variables. GGST = genotype guided statin therapy; BMI = body mass index; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol; NCEP = National Cholesterol Education Program.